Home › Funds › Prudential Financial › CLOV
Prudential Financial position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q2 2026)69.90K sh
Reported value held$366.28K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 64.87K | $139.00K | New |
| Q3 2022 | 24.37K | $41.00K | Reduce |
| Q4 2022 | 24.37K | $22.65K | Hold |
| Q1 2023 | 24.37K | $20.59K | Hold |
| Q2 2024 | 72.40K | $89.05K | New |
| Q2 2025 | 51.29K | $143.10K | New |
| Q3 2025 | 51.48K | $157.53K | Hold |
| Q4 2025 | 24.60K | $57.81K | Reduce |
| Q1 2026 | 63.57K | $111.88K | Add |
| Q2 2026 | 69.90K | $366.28K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Marshall Wace 1.56M sh · $8.19M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026
- BNY Mellon 1.21M sh · $6.35M · Q2 2026